7 practice questions available

Practice now

Practice this topic with real NCLEX questions.

NurseSavvy Cheat SheetProcedure

Medications & Pregnancy Safety

Pregnancy drug safety centers on teratogenic risk, which varies by trimester and mechanism. The first trimester (organogenesis, weeks 3-8) carries the highest risk for structural defects, but some agents (ACE inhibitors/ARBs, NSAIDs) are most dangerous in the second and third trimesters. The FDA retired the A-B-C-D-X letter categories in 2015, yet the nurse must still recognize which drugs are absolute no-go versus which have safe pregnancy alternatives — and verify pregnancy status before giving any high-risk medication.

isotretinoin Hallmark
former category X; craniofacial, cardiac, CNS defects from a single dose; requires iPLEDGE program
warfarin
crosses placenta; nasal hypoplasia, stippled epiphyses — switch to heparin
ACE inhibitors
renal agenesis, oligohydramnios; most dangerous 2nd/3rd trimester
angiotensin receptor blockers
same fetal renal risk as ACE inhibitors
methotrexate
folate antagonist; potent abortifacient; neural tube defects
valproic acid
highest-risk AED; neural tube defects
tetracyclines
tooth discoloration, impaired bone growth after week 16
statins
disrupt fetal cholesterol synthesis — discontinue
NSAIDs after 20 weeks
premature ductus arteriosus closure, oligohydramnios
misoprostol
uterine stimulant / abortifacient
live vaccines
contraindicated in pregnancy
heparin Hallmark
too large to cross the placenta; the anticoagulant of choice (LMWH/UFH)
acetaminophen
preferred analgesic over NSAIDs
penicillins
safe for infections
cephalosporins
safe for infections
labetalol
safe for chronic hypertension
methyldopa
safe for chronic hypertension
insulin
first-line for gestational diabetes per ACOG
low-dose aspirin
81 mg; recommended in high-risk pregnancy for preeclampsia prevention
verify pregnancy status before high-risk meds
plan medication changes before conception
organogenesis weeks 3-8, often before pregnancy is known
transition teratogens under provider supervision
do not stop abruptly — e.g., taper AEDs, bridge anticoagulation
start high-dose folic acid preconceptionally
4 mg/day for clients on AEDs
reconcile every prescribed and OTC medication
never change any medication without the provider Hallmark
do not start, stop, or alter a dose on your own
report a positive pregnancy test immediately
if on any teratogen
stop herbal supplements
unestablished safety; some contain uterine stimulants
continue the prenatal vitamin
never withhold folic acid during reconciliation
do not stop an antidepressant on your own
untreated maternal depression also carries risk
use reliable contraception on teratogens
e.g., isotretinoin iPLEDGE
Report Nowescalate immediately
isotretinoin in pregnancy Hallmark
absolute contraindication; stop — severe craniofacial/cardiac/CNS defects
warfarin in pregnancy
stop and switch to heparin
ACE inhibitor or ARB in pregnancy
stop and switch to labetalol/methyldopa
methotrexate in pregnancy
abortifacient — discontinue
valproic acid in pregnancy
highest teratogenic AED — provider must transition
statin in pregnancy
discontinue
NSAID after 20 weeks
premature ductus closure — switch to acetaminophen

Clinical Pearl

Warfarin crosses, heparin doesn't. If she's pregnant and needs anticoagulation, think heparin — the molecule is too large to cross the placental barrier. And never confuse 'avoid if possible' with 'never give': isotretinoin, ACE inhibitors, methotrexate, valproate, and statins are hard stops.

NurseSavvy™·nursesavvy.com

Ready to practice this topic?

Get a personalized study plan built around this topic — free to try, no card needed.